[
  {
    "ts": "2025-11-12T02:12:46+00:00",
    "headline": "Danaher (DHR): Evaluating Valuation After Modest Share Price Rebound",
    "summary": "Danaher (DHR) shares have edged modestly higher over the past month, gaining about 7%. Investors seem to be weighing up recent performance and the company’s underlying growth trends as they look for clues about its outlook. See our latest analysis for Danaher. While Danaher has been clawing back some ground with a 6.6% share price gain over the last month, the bigger picture tells a more cautious story, with a one-year total shareholder return of -9.4%. Recent momentum suggests investors are...",
    "url": "https://finance.yahoo.com/news/danaher-dhr-evaluating-valuation-modest-021246925.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0a70a3df-a5fa-315a-ad18-fb43ea2041f3",
      "content": {
        "id": "0a70a3df-a5fa-315a-ad18-fb43ea2041f3",
        "contentType": "STORY",
        "title": "Danaher (DHR): Evaluating Valuation After Modest Share Price Rebound",
        "description": "",
        "summary": "Danaher (DHR) shares have edged modestly higher over the past month, gaining about 7%. Investors seem to be weighing up recent performance and the company’s underlying growth trends as they look for clues about its outlook. See our latest analysis for Danaher. While Danaher has been clawing back some ground with a 6.6% share price gain over the last month, the bigger picture tells a more cautious story, with a one-year total shareholder return of -9.4%. Recent momentum suggests investors are...",
        "pubDate": "2025-11-12T02:12:46Z",
        "displayTime": "2025-11-12T02:12:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/cd882777b6cc15b2360b466e842457e4",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rZdbQ9ZLZdOFwFfglEWXFw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/cd882777b6cc15b2360b466e842457e4.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s_CYjA6sgJiGa0tfTcFO6w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/cd882777b6cc15b2360b466e842457e4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/danaher-dhr-evaluating-valuation-modest-021246925.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/danaher-dhr-evaluating-valuation-modest-021246925.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:09:00+00:00",
    "headline": "IDBS announces i3 2026-An exclusive customer and partner event on data management innovation in BioPharma",
    "summary": "Following the success of i3 2025, IDBS, a Danaher company and leading provider of cloud software for BioPharma companies, is excited to announce that its flagship customer and partner event, i3 2026, will take place in Boston, USA on May 18, 2026.",
    "url": "https://finance.yahoo.com/news/idbs-announces-i3-2026-exclusive-150900650.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "8fdb2741-f0c2-34b5-891d-ab556611cb05",
      "content": {
        "id": "8fdb2741-f0c2-34b5-891d-ab556611cb05",
        "contentType": "STORY",
        "title": "IDBS announces i3 2026-An exclusive customer and partner event on data management innovation in BioPharma",
        "description": "",
        "summary": "Following the success of i3 2025, IDBS, a Danaher company and leading provider of cloud software for BioPharma companies, is excited to announce that its flagship customer and partner event, i3 2026, will take place in Boston, USA on May 18, 2026.",
        "pubDate": "2025-11-12T15:09:00Z",
        "displayTime": "2025-11-12T15:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c9e3de61a91292c536998dc9562a73e4",
          "originalWidth": 400,
          "originalHeight": 123,
          "caption": "IDBS logo (PRNewsfoto/IDBS)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TFbqzXcvyp65d9OADso6pQ--~B/aD0xMjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c9e3de61a91292c536998dc9562a73e4.cf.webp",
              "width": 400,
              "height": 123,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SEXuvarp7HOiWwiVmiH19g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c9e3de61a91292c536998dc9562a73e4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/idbs-announces-i3-2026-exclusive-150900650.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/idbs-announces-i3-2026-exclusive-150900650.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            },
            {
              "symbol": "4523.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:00:00+00:00",
    "headline": "2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon",
    "summary": "If you have decades of investing runway left, consider these two top healthcare stocks.",
    "url": "https://www.fool.com/investing/2025/11/12/2-healthcare-stocks-for-individual-investors-with/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "816ede35-9643-3296-aa56-8e03bd314898",
      "content": {
        "id": "816ede35-9643-3296-aa56-8e03bd314898",
        "contentType": "STORY",
        "title": "2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon",
        "description": "",
        "summary": "If you have decades of investing runway left, consider these two top healthcare stocks.",
        "pubDate": "2025-11-12T15:00:00Z",
        "displayTime": "2025-11-12T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/52c7b191a54afd7f3577d967a763ff08",
          "originalWidth": 1400,
          "originalHeight": 738,
          "caption": "DNA-sequencing researchers at work in a science lab.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6jMnxkTEQF_qcFTOdyHxA--~B/aD03Mzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/52c7b191a54afd7f3577d967a763ff08.cf.webp",
              "width": 1400,
              "height": 738,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FNFHf0hgANg0mUFP7FhJbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/52c7b191a54afd7f3577d967a763ff08.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/2-healthcare-stocks-for-individual-investors-with/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-healthcare-stocks-individual-investors-150000552.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]